Innoviva INVA
NASDAQ INVA
$21.33 -0.02 (-0.09%)
As of: Sep 4, 2026 · 3:59 PM EDT

Innoviva (INVA) Total Liabilities (2010 - 2026)

Innoviva's (INVA) quarterly Total Liabilities came in at $200000.0 in Q1 2026, little changed YoY from $200000.0 in Q1 2025, and little changed on a QoQ basis from $200000.0 in Q4 2025.

Analysis

Innoviva (INVA) Total Liabilities (2010 - 2026) Analysis & Trends

Innoviva (INVA) has 17 years of Total Liabilities data on file, last reported at $200000.0 in Q1 2026.

  • Quarterly Total Liabilities changed 0.0% year-over-year to $200000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $200000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $200000.0, changed 0.0% from the prior year.
  • Total Liabilities held at $200000.0 in Q1 2026, from $200000.0 in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $18.7 million in Q2 2022 to a low of $100000.0 in Q4 2023.
  • A 5-year average of $2.5 million and a median of $600000.0 in 2024 frame the typical range for Total Liabilities.
  • The widest YoY moves for Total Liabilities: up 700.0% in 2022, down 99.98% in 2022.
  • Tracing INVA's Total Liabilities over 5 years: stood at $1.6 million in 2022, then plunged by 93.75% to $100000.0 in 2023, then surged by 100.0% to $200000.0 in 2024, then changed by 0.0% to $200000.0 in 2025, then changed by 0.0% to $200000.0 in 2026.
  • The last three Total Liabilities figures came in at $200000.0 (Q1 2026), $200000.0 (Q4 2025), and $100000.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 7.18 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 10.02 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.62 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 4.20 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 1.72 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 4.00 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 4.20 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 10.03 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.35 Bn
10 Innoviva 1.56 Bn 984.81 Mn 90.62 Mn 100,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 100,000.00
Mar 31, 2026 200,000.00
Dec 31, 2025 100,000.00
Sep 30, 2025 100,000.00
Jun 30, 2025 100,000.00
Mar 31, 2025 200,000.00
Dec 31, 2024 200,000.00
Sep 30, 2024 800,000.00
Jun 30, 2024 600,000.00
Mar 31, 2024 1.80 Mn
Dec 31, 2023 100,000.00
Sep 30, 2023 1.10 Mn
Jun 30, 2023 700,000.00
Mar 31, 2023 4.10 Mn
Dec 31, 2022 1.60 Mn
Sep 30, 2022 200,000.00
Jun 30, 2022 18.70 Mn
Mar 31, 2022 12.43 Mn
Dec 31, 2021 200,000.00
Sep 30, 2021 395.43 Mn